VIE/HCAH (VIE/HCAH)

Vienna Stock Exchange: VIE/HCAH · EUR

€415

+19.00 (+4.8%)· Recorded snapshot

Market cap	90B
Revenue (ttm)	69.3B
Net income (ttm)	6B
EPS (ttm)	€27.2
P/E (trailing)	15.3x
P/E (forward)	15.7x
Dividend	€2.72 (0.66%)
Volume	79

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 69.3B
Net income (ttm): 6B
EPS (ttm): €27.2
P/E (trailing): 15.3x
P/E (forward): 15.7x
Market cap: 90B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E15.7

P25 n/aP50 n/aP75 n/a

Trailing P/E15.3

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC21.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.6%

Nasdaq Composite-2.3%

Dow Jones Industrial Average+1.9%

Russell 2000+1.8%

All VIE/HCAH indicators

Market & fundamental data

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-10-27
Employees	275,000
Employees change	4,000
Employees growth	1.27%
Enterprise value	EUR 139.3B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-10-22
Fiscal year end	December
Founded	1968
Industry	Medical Care Facilities
Is primary listing	No
ISIN number	US40412C1018
Last earnings date	2026-10-27
Last refreshed	2026-10-29
Market cap	EUR 90B
Next earnings date	2027-01-22
Price	EUR 415.40
Price currency	EUR
Sector	Healthcare
SIC code	8062
Stock price date	2026-10-28
Symbol	vie/HCAH
Website	https://www.hcahealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	12.9x
Average P/E ratio (3Y)	14.91x
Average P/E ratio (5Y)	13.5x
Earnings yield	6.54%
EV/Earnings	23.35x
EV/EBIT	12.81x
EV/EBITDA	9.2x
EV/FCF	26.49x
EV/Sales	1.97x
FCF / EV yield	3.78%
FCF yield	5.85%
Forward P/E	15.66x
Lynch fair value	EUR 137.74
Lynch upside	-66.84%
P/(FCF - SBC) ratio	18.35x
P/(OCF - SBC) ratio	9.49x
P/E ratio	15.29x
P/FCF ratio	17.11x
P/OCF ratio	9.15x
P/S ratio	1.3x
Price/EBITDA ratio	6.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	15.31%
EBITDA margin	20.06%
Effective tax rate	20.6%
FCF margin	7.44%
Gross margin	42.76%
Operating margin	15.31%
Pretax margin	12.48%
Profit margin	8.61%
Profit per employee	EUR 21,698
Profitable quarters	66
Profitable years	18
Revenue per employee	EUR 252,015
ROA	12.23%
ROA (5Y)	11.64%
ROCE	27.6%
ROIC	21.36%
ROIC (5Y)	19.69%
SBC / revenue	0.51%
Tax / revenue	2.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	17.06%
EPS growth (Q)	4.45%
EPS growth (QoQ)	-4.6%
EPS growth 10Y	16.95%
EPS growth 3Y	13.98%
EPS growth 5Y	9.12%
EPS growth quarters	6
EPS growth years	2
FCF growth	-26.22%
FCF growth (Q)	-0.77%
FCF growth (QoQ)	181.16%
FCF growth 3Y	10.93%
Gross profit growth	9.35%
Gross profit growth (Q)	5.38%
Gross profit growth 3Y	11.24%
Gross profit growth 5Y	8.44%
Net income growth	6.81%
Net income growth (Q)	-3.9%
Net income growth (QoQ)	-7.06%
Net income growth 3Y	5.83%
Net income growth 5Y	0.63%
Net income growth quarters	6
Net income growth years	2
OCF growth	-12.99%
OCF growth (Q)	1.02%
OCF growth (QoQ)	91.05%
OCF growth 10Y	7.32%
OCF growth 3Y	6.36%
OCF growth 5Y	30.66%
Operating income growth	3.6%
Operating income growth (Q)	-0.71%
Operating income growth 3Y	9.26%
Operating income growth 5Y	4.35%
Revenue growth	5.82%
Revenue growth (Q)	3.59%
Revenue growth (QoQ)	-1.88%
Revenue growth 10Y	6.71%
Revenue growth 3Y	7.61%
Revenue growth 5Y	6.3%
Revenue growth quarters	15
Revenue growth years	16

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -4.6B
Depreciation and amortization	EUR 3.4B
EBIT	EUR 10.6B
EBITDA	EUR 13.9B
EPS	EUR 27.16
Financing cash flow	EUR -4.6B
Free cash flow	EUR 5.3B
Free cash flow minus SBC	EUR 4.9B
Gross profit	EUR 29.6B
Income taxes	EUR 1.8B
Investing cash flow	EUR -5.3B
Net borrowing	EUR 5.2B
Net cash flow	EUR -78.4M
Net income	EUR 6B
Operating cash flow minus SBC	EUR 9.5B
Operating income	EUR 10.6B
Revenue	EUR 69.3B
Stock-based compensation	EUR 355.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR -32.75
Debt / EBITDA	3.12
Debt / FCF	8.78
Interest coverage	5.1
Long-term assets	EUR 41.3B
Long-term liabilities	EUR 42.2B
Net cash (debt)	EUR -45.4B
Net cash / market cap	-50.42%
Net debt / EBITDA	3.26
Net debt / FCF	8.63
Piotroski F-Score	6
Property, plant and equipment	EUR 31B
Shareholders' equity	EUR -4B
Tangible book value	EUR -17B
Tangible book value per share	EUR -78.15
Total assets	EUR 55.9B
Total cash	EUR 799.6M
Total debt	EUR 46.2B
Total liabilities	EUR 59.9B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.28
Current assets	EUR 14.6B
Current liabilities	EUR 17.8B
Current ratio	0.82
Inventory turnover	26.47
Net working capital	EUR 3.2B
Quick ratio	0.63
Working capital	EUR -3.1B
Working capital turnover	-22.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	8.7%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-12-29
Dividend payment years	2
Dividend payout frequency	Quarterly
Dividend per share	EUR 2.72
Dividend yield	0.66%
Ex-dividend date	2026-12-15
Last dividend	EUR 0.70
Payout ratio	10.05%
Shareholder yield	9.35%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	4.79%
1M price change	4.87%
1M total return	4.87%
1W price change	-3.58%
1W total return	-3.58%
20-day SMA	EUR 400.62
52-week high	EUR 430.20
52-week high date	2026-10-27
52-week low	EUR 341.90
52-week low date	2026-09-09
All-time high	EUR 430.20
All-time high date	2026-10-27
All-time low	EUR 341.90
All-time low date	2026-09-09
Average true range (ATR)	EUR 8.33
Average volume	5
Change from 52-week high	-3.44%
Change from 52-week low	21.5%
Change from all-time high	-7.86%
Change from all-time low	15.94%
Change from open	3.18%
Day's gap	1.56%
Dollar volume	EUR 32,817
High price	EUR 415.40
Low price	EUR 397.80
Monthly RSI	0
Open price	EUR 402.60
Position in 52-week range	100%
Previous close	EUR 396.40
Price vs 20-day SMA	-1.05%
Relative volume	15.96
RSI	50.89
Sharpe ratio	3.34
Sortino ratio	4.77
Volume	79
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	144.3M
Shares change (QoQ)	-2.52%
Shares change (YoY)	-8.7%
Shares held by insiders	1.43%
Shares held by institutions	62.23%
Short ratio	3.7 days

Deeper analysis on VIE/HCAH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this VIE/HCAH report

Is a complete VIE/HCAH research report available?

No complete published report is available for vie/HCAH (VIE/HCAH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

90B

Revenue (ttm)

69.3B

Net income (ttm)

EPS (ttm)

€27.2

P/E (trailing)

15.3x

P/E (forward)

15.7x

Dividend

€2.72 (0.66%)

Volume

Metric

Value

Amount currency

EUR

Country

United States

Country code

Earnings date

2026-10-27

Employees

275,000

Employees change

4,000

Employees growth

1.27%

Enterprise value

EUR 139.3B

Exchange

Vienna Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-10-22

Fiscal year end

December

Founded

1968

Industry

Medical Care Facilities

Is primary listing

ISIN number

US40412C1018

Last earnings date

2026-10-27

Last refreshed

2026-10-29

Market cap

EUR 90B

Next earnings date

2027-01-22

Price

EUR 415.40

Price currency

EUR

Sector

Healthcare

SIC code

8062

Stock price date

2026-10-28

Symbol

vie/HCAH

Website

https://www.hcahealthcare.com

Metric

Value

Average P/E ratio (10Y)

12.9x

Average P/E ratio (3Y)

14.91x

Average P/E ratio (5Y)

13.5x

Earnings yield

6.54%

EV/Earnings

23.35x

EV/EBIT

12.81x

EV/EBITDA

9.2x

EV/FCF

26.49x

EV/Sales

1.97x

FCF / EV yield

3.78%

FCF yield

5.85%

Forward P/E

15.66x

Lynch fair value

EUR 137.74

Lynch upside

-66.84%

P/(FCF - SBC) ratio

18.35x

P/(OCF - SBC) ratio

9.49x

P/E ratio

15.29x

P/FCF ratio

17.11x

P/OCF ratio

9.15x

P/S ratio

1.3x

Price/EBITDA ratio

6.47x

Metric

Value

EBIT margin

15.31%

EBITDA margin

20.06%

Effective tax rate

20.6%

FCF margin

7.44%

Gross margin

42.76%

Operating margin

15.31%

Pretax margin

12.48%

Profit margin

8.61%

Profit per employee

EUR 21,698

Profitable quarters

Profitable years

Revenue per employee

EUR 252,015

ROA

12.23%

ROA (5Y)

11.64%

ROCE

27.6%

ROIC

21.36%

ROIC (5Y)

19.69%

SBC / revenue

0.51%

Tax / revenue

2.57%

Metric

Value

EPS growth

17.06%

EPS growth (Q)

4.45%

EPS growth (QoQ)

-4.6%

EPS growth 10Y

16.95%

EPS growth 3Y

13.98%

EPS growth 5Y

9.12%

EPS growth quarters

EPS growth years

FCF growth

-26.22%

FCF growth (Q)

-0.77%

FCF growth (QoQ)

181.16%

FCF growth 3Y

10.93%

Gross profit growth

9.35%

Gross profit growth (Q)

5.38%

Gross profit growth 3Y

11.24%

Gross profit growth 5Y

8.44%

Net income growth

6.81%

Net income growth (Q)

-3.9%

Net income growth (QoQ)

-7.06%

Net income growth 3Y

5.83%

Net income growth 5Y

0.63%

Net income growth quarters

Net income growth years

OCF growth

-12.99%

OCF growth (Q)

1.02%

OCF growth (QoQ)

91.05%

OCF growth 10Y

7.32%

OCF growth 3Y

6.36%

OCF growth 5Y

30.66%

Operating income growth

3.6%

Operating income growth (Q)

-0.71%

Operating income growth 3Y

9.26%

Operating income growth 5Y

4.35%

Revenue growth

5.82%

Revenue growth (Q)

3.59%

Revenue growth (QoQ)

-1.88%

Revenue growth 10Y

6.71%

Revenue growth 3Y

7.61%

Revenue growth 5Y

6.3%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

EUR -4.6B

Depreciation and amortization

EUR 3.4B

EBIT

EUR 10.6B

EBITDA

EUR 13.9B

EPS

EUR 27.16

Financing cash flow

EUR -4.6B

Free cash flow

EUR 5.3B

Free cash flow minus SBC

EUR 4.9B

Gross profit

EUR 29.6B

Income taxes

EUR 1.8B

Investing cash flow

EUR -5.3B

Net borrowing

EUR 5.2B

Net cash flow

EUR -78.4M

Net income

EUR 6B

Operating cash flow minus SBC

EUR 9.5B

Operating income

EUR 10.6B

Revenue

EUR 69.3B

Stock-based compensation

EUR 355.8M

Metric

Value

Book value per share

EUR -32.75

Debt / EBITDA

3.12

Debt / FCF

8.78

Interest coverage

5.1

Long-term assets

EUR 41.3B

Long-term liabilities

EUR 42.2B

Net cash (debt)

EUR -45.4B

Net cash / market cap

-50.42%

Net debt / EBITDA

3.26

Net debt / FCF

8.63

Piotroski F-Score

Property, plant and equipment

EUR 31B

Shareholders' equity

EUR -4B

Tangible book value

EUR -17B

Tangible book value per share

EUR -78.15

Total assets

EUR 55.9B

Total cash

EUR 799.6M

Total debt

EUR 46.2B

Total liabilities

EUR 59.9B

Metric

Value

Asset turnover

1.28

Current assets

EUR 14.6B

Current liabilities

EUR 17.8B

Current ratio

0.82

Inventory turnover

26.47

Net working capital

EUR 3.2B

Quick ratio

0.63

Working capital

EUR -3.1B

Working capital turnover

-22.46

Metric

Value

Buyback yield / dilution

8.7%

Dividend growth

Dividend growth years

Dividend payment date

2026-12-29

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

EUR 2.72

Dividend yield

0.66%

Ex-dividend date

2026-12-15

Last dividend

EUR 0.70

Payout ratio

10.05%

Shareholder yield

9.35%

Metric

Value

1D price change

4.79%

1M price change

4.87%

1M total return

4.87%

1W price change

-3.58%

1W total return

-3.58%

20-day SMA

EUR 400.62

52-week high

EUR 430.20

52-week high date

2026-10-27

52-week low

EUR 341.90

52-week low date

2026-09-09

All-time high

EUR 430.20

All-time high date

2026-10-27

All-time low

EUR 341.90

All-time low date

2026-09-09

Average true range (ATR)

EUR 8.33

Average volume

Change from 52-week high

-3.44%

Change from 52-week low

21.5%

Change from all-time high

-7.86%

Change from all-time low

15.94%

Change from open

3.18%

Day's gap

1.56%

Dollar volume

EUR 32,817

High price

EUR 415.40

Low price

EUR 397.80

Monthly RSI

Open price

EUR 402.60

Position in 52-week range

100%

Previous close

EUR 396.40

Price vs 20-day SMA

-1.05%

Relative volume

15.96

RSI

50.89

Sharpe ratio

3.34

Sortino ratio

4.77

Volume

Weekly RSI

Metric

Value

Float

144.3M

Shares change (QoQ)

-2.52%

Shares change (YoY)

-8.7%

Shares held by insiders

1.43%

Shares held by institutions

62.23%

Short ratio

3.7 days

VIE/HCAH (VIE/HCAH)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/HCAH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/HCAH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/HCAH

Frequently asked questions

VIE/HCAH (VIE/HCAH)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/HCAH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/HCAH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/HCAH

Frequently asked questions